New drug tested for tough liver disease
NCT ID NCT05104853
Summary
This study tested an experimental drug called CNP-104 in adults with primary biliary cholangitis (PBC), a chronic liver disease, who weren't responding well to standard medications. Forty-two participants received either CNP-104 or a placebo infusion to check its safety and see if it could improve liver health and symptoms like itching over two years of follow-up.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic - Florida
Weston, Florida, 33331, United States
-
Digestive Healthcare of Georgia
Atlanta, Georgia, 30309, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Florida Research Institute
Lakewood Rch, Florida, 34211-4930, United States
-
GI PROS Research
Naples, Florida, 34102, United States
-
Henry Ford Health System
Novi, Michigan, 48377, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
OM Research
Lancaster, California, 93534, United States
-
Peak Gastroenterology Associates
Colorado Springs, Colorado, 80907, United States
-
Southern California Research Center
Coronado, California, 92118, United States
-
Texas Liver Institute
San Antonio, Texas, 78215, United States
-
University of California Davis Health
Sacramento, California, 95817, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Florida - Hepatology Research
Gainesville, Florida, 32610, United States
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
-
Yale School of Medicine
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.